Mymee

Mymee is a New York-based digital therapeutics company founded in 2016, targeting the large and underserved market of patients with autoimmune diseases and long COVID who experience uncontrolled symptoms. Its core offering is a personalized care platform combining a mobile app, a proprietary data analytics engine, and dedicated health coaches to help patients identify and avoid individual triggers, leading to clinically validated reductions in pain, fatigue, and other symptoms. The company has garnered support from industry leaders and published peer-reviewed research, positioning itself as a novel, data-driven adjunct to conventional autoimmune care.

AI/ML-powered digital care platform combining a mobile app for tracking exposome/symptom data, a proprietary analytics engine to identify personal triggers, and a human health coach for guided personalized trials.

Mymee competes in the broad digital therapeutics and chronic care management space. Direct competitors may include other digital health companies focusing on autoimmune diseases (e.g., Health Storylines, MyHealthTeams' social networks) and general chronic condition platforms. Its key differentiation is its specific focus on the exposome, its AI-driven n-of-1 trial methodology, and the integration of dedicated health coaching.